Recurrent prosthetic endocarditis in a 21-year old patient with renal transplantation treated with allogeneic homograft
Authors:
F. Sabol 3; M. Jakubová 1; A. Kolesár 3; B. Stančák 2; M. Beňa 3; J. Podracký 2; Ľ. Podracká 4; P. Čadník 1; J. Špatenka 5
Authors‘ workplace:
Klinika anestéziológie a intenzívnej medicíny VÚSCH, a. s., Košice, Slovenská republika, prednosta doc. MUDr. Pavol Török, CSc.
1; Klinika kardiológie VÚSCH, a. s., Košice, Slovenská republika, prednosta doc. MUDr. Branislav Stančák, CSc.
2; Klinika srdcovej chirurgie VÚSCH, a. s., Košice, Slovenská republika, prednosta MUDr. František Sabol, PhD.
3; I. klinika detí a dorastu DFN Košice, Slovenská republika, prednosta prof. MUDr. Ľudmila Podracká, CSc.
4; Transplantační centrum FN Motol Praha, Česká republika, přednosta prim. MUDr. Jaroslav Špatenka, CSc.
5
Published in:
Vnitř Lék 2012; 58(6): 494-498
Category:
Case Reports
Overview
Prosthetic infective endocarditis is a possible complication of implantation of a prosthetic cardiac valve. Without early and effective treatment, it can have fatal consequences. One treatment option is use of an allogeneic cryopreserved homograft. This case report presents a 21-year old patient after kidney transplantation due to hereditary nephrotic syndrome and aortic valve replacement with aortic conduits. After fever was noted in the patient, prosthetic infective endocarditis was diagnosed by echocardiography and also confirmed by CT-3D examination. The cryopreserved aortic homograft was implanted at the Department of Cardiac Surgery. This along with additional conservative management effectively treated the infection. Based on literature data and our own experience, we believe that the treatment of prosthetic endocarditis after aortic valve replacement with cryopreserved homograft can be a method of choice.
Key words:
allogeneic homograft – infective endocarditis – kidney transplant
Sources
1. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318–1330.
2. Beneš J, Gregor P, Mokráček A. Infekční endokarditida. Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 49: K157–K171.
3. Schilberger J, Brychta T, Maňoušek J et al. Úskalí diagnostiky infekční endokarditidy. Vnitř Lék 2001; 47: 375–380.
4. Horstkotte D, Follath F, Gutschik E et al. Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for racticeGuidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25: 1–37.
5. Freeman R. Prevention of prosthetic valve endocarditis. J Hosp Infect 1995; 30 (Suppl): 44–53.
6. Jault F, Gandjbakhch I, Chastre JC et al. Prosthetic valve endocarditis with ring abscesses. Surgical management and long term results. J Thorac Cardiovasc Surg 1993; 105: 1106–1113.
7. Prat A, Fabre OH, Vincentelli A et al. Ross operation and mitral homograft for aortic and tricuspid valve endocarditis. Ann Thorac Surg 1998; 65: 1450–1452.
8. Guerra JM, Tornos MP, Parmanyer-Miralda G et al. Long term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86: 63–68.
9. Mokráček A, Špatenka J, Šulda M et al. Aortální alograft (homograft) v léčbe chlopen ních srdečních vad dospelých s durazem na léčbu infekční endokarditidy aortální chlopně. Vnitř Lék 2007; 53: 54–62.
10. Horstkotte D, Follath F, Gutschink E et al. Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for PracticeGuidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25: 267–276.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2012 Issue 6
Most read in this issue
- Teleangiectasia hereditaria haemorrhagica –Osler-Weber-Rendu syndrome. Case study and treatment experience
- Disturbances of hemostasis in sepsis
- Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group
- An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis – a practice-based perspective of vancomycin and gentamycin therapies